Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

InnerBuddies

Biotechnology Company
2021
Nov-50
11-50
Venlo, Limburg, The Netherlands
  • Consumer Healthcare
  • Nutraceuticals (e.g. Supplements)
  • Personalized Medicine Technologies
  • Probiotics
  • Services (Patient care)

Innovation

Industry Problem

Diet and supplement guidance rarely reflects the individual composition and function of a person’s gut microbiome.

R&D Focus

At-home microbiome testing, DNA sequencing, AI recommendations and white-label gut-health platforms.

Innovative Solution

A stool-test service and Gut Health Operating System analyze microbial composition and pathways, then produce personalized diet, probiotic and prebiotic recommendations.

About

InnerBuddies is a Dutch biotechnology company specializing in gut microbiome analysis. The company offers a gut microbiome DNA test that provides personalized nutrition, probiotic, and prebiotic recommendations based on an individual’s microbiome composition. Additionally, InnerBuddies provides a subscription-based recipe platform that tailors meal plans based on microbiome test results, making it easier for users to adopt gut-friendly dietary habits. History InnerBuddies was founded in October 2021 in the Netherlands as a spin-off from the University of Maastricht. The company was established by Koen Venema, a professor at Maastricht University, along with Jella Theeuwen (dietitian), Joachim Schneider (former CEO of Bayer Vegetable Seeds), and Roy Lenders (ex-partner at Ernst & Young Advisory). In April 2024, co-founder Jella Theeuwen left InnerBuddies. At the same time, Crysta Kriek and Fenna Sonnemans joined the management team.

Products

Product

InnerBuddies Gut Microbiome Test and subscription-based personalized nutrition tools.

Star Product

Gut Microbiome Test, the core consumer service and data input for the company’s recommendation platform.

Demo Product or Complete Product?

Complete consumer tests and B2B platform services are commercially available.

Future Plan

Market Expansion

Actively seeking international laboratories, clinics and health platforms to launch white-label microbiome testing services.

Investment Funding

Raised a €225,000 pre-seed round from Limburg Technology Investment Fund, FoodFriends and Rolf Smeets.

M&A and Collabs

Collab

Astrolab BiotecnologĂ­a: collaboration on the next generation of a Gut Microbiome Health Index.

Collab

B2B laboratory, clinic and health-platform partners can integrate the company’s white-label analytics and recommendation engine.

Something missing or incorrect on this page? Help us enrich this information